MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring, was featured in a recent article published by the Ritz Herald. The piece reviews MetAlert’s SmartSole(R), discussing it as a better solution as compared to the Apple Inc. (NASDAQ: AAPL) Air Tag. The Apple product is a tracking device that uses a network of nearby Apple iPhones to bounce signals off. “Not surprisingly, given Apple’s history, the Air Tag was a hit, especially amongst those traveling with an expensive MacBook laptop or other high-end goods. It was also embraced by parents who slipped an Air Tag into their children’s pockets or backpacks to keep tabs on their location. Now, families of dementia patients are using Air Tags to help locate a loved one if they wander,” reads the publication, further delving into the benefits of MetAlert’s SmartSole. “MetAlert (OTC: MLRT) is a Los Angeles-based company that focuses on healthcare and medical technology products for consumers. Its flagship GPS SmartSole tracker is the perfect solution for the problem of wandering because it was made specifically for this purpose. The SmartSole is an insole for shoes that comes equipped with a GPS and cellular tracking device built into it. It is easy to conceal, and patients are less likely to forget their shoes at home before they head out the door. Best of all, the mobile app works with both iPhone and Android operating systems. Every five minutes, the SmartSole will send their location to the cloud and send notifications and alerts directly to your phone. Set your own boundaries, and if the patient wanders outside of them you’ll be alerted immediately. MetAlert also cites that the SmartSole works in all 50 states and uses the T-Mobile 4G wireless network rather than Bluetooth like Air Tags.”
To view the full article, visit https://ibn.fm/7Oeso
About MetAlert Inc.
MetAlert and its subsidiaries are engaged in designing, developing, manufacturing, distributing, selling, and licensing products, services and intellectual property in the GPS/BLE wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. With over 20 years of experience and an extensive patent portfolio, MetAlert is a leading solution provider for consumers/patients afflicted with Alzheimer’s, dementia and autism. This market represents approximately 2.9% of the world’s population. The company offers global end-to-end hardware, software and connectivity solutions in addition to developing two-way tracking technologies, which seamlessly integrate with consumer products, enterprise and government agency applications. Utilizing the latest in miniaturized, low power consumption GPS, cellular, RF, NFC, and BLE technologies, MetAlert solutions enable caregivers to track and monitor patients in real time. Known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible wearable technology tracking device was created for those at risk of wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based business model is built around technology innovation with intellectual property protection. The company has international distributors servicing customers across the globe with subscribers in over 40 countries and is a U.S. military government contractor. Other customers include public health authorities, municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes, and consumers. For more information about the company, visit www.MetAlert.com.
NOTE TO INVESTORS: The latest news and updates relating to MLRT are available in the company’s newsroom at https://ibn.fm/MLRT
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork
